The docking protein FRS2a is a critical regulator of VEGF receptors signaling

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 15, 2014, Pages 5514-5519

  Chen, Pei Yu ^a   Qin, Lingfeng ^a   Zhuang, Zhen W ^a   Tellides, George ^a   Lax, Irit ^a   Schlessinger, Joseph ^a   Simons, Michael ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fgf Receptor; Map Kinase; Phosphorylation; Receptor Kinase Inhibition; Signal Transduction

Indexed keywords

DOCKING PROTEIN; FIBROBLAST GROWTH FACTOR RECEPTOR 2 ALPHA PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; FRS2 PROTEIN, HUMAN; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PRIMER DNA; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE DELETION; HUMAN; IN VIVO STUDY; LYMPH VESSEL; LYMPHANGIOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; CELL MOTION; GENE EXPRESSION PROFILING; GENE VECTOR; GENETICS; HEK293 CELL LINE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LASER DOPPLER FLOWMETRY; LENTIVIRINAE; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; PHOSPHORYLATION; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR KINASE INHIBITION; UMBILICAL VEIN ENDOTHELIAL CELL;

FGF RECEPTOR; MAP KINASE; PHOSPHORYLATION; RECEPTOR KINASE INHIBITION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL MOVEMENT; DNA PRIMERS; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; GENETIC VECTORS; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LASER-DOPPLER FLOWMETRY; LENTIVIRUS; MEMBRANE PROTEINS; MICE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SIGNAL TRANSDUCTION; X-RAY MICROTOMOGRAPHY;

EID: 84898827703     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1404545111     Document Type: Article

References (30)

1. Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473(7347):298-307.
2. Lohela M, Bry M, Tammela T, Alitalo K (2009) VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 21(2):154-165.
3. Benedito R, et al. (2012) Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling. Nature 484(7392):110-114.
4. Wang Y, et al. (2010) Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465(7297):483-486.
5. Sawamiphak S, et al. (2010) Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature 465(7297):487-491.
6. Lee S, et al. (2007) Autocrine VEGF signaling is required for vascular homeostasis. Cell 130(4):691-703.
7. Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L (2011) Signal transduction by vascular endothelial growth factor receptors. Biochem J 437(2):169-183.
8. Kouhara H, et al. (1997) A lipid-Anchored Grb2-binding protein that links FGFreceptor activation to the Ras/MAPK signaling pathway. Cell 89(5):693-702.
9. Gotoh N, Laks S, Nakashima M, Lax I, Schlessinger J (2004) FRS2 family docking proteins with overlapping roles in activation of MAP kinase have distinct spatialtemporal patterns of expression of their transcripts. FEBS Lett 564(1-2):14-18.
10. Ong SH, et al. (2000) FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors. Mol Cell Biol 20(3):979-989.
11. Sato T, Gotoh N (2009) The FRS2 family of docking/scaffolding adaptor proteins as therapeutic targets of cancer treatment. Expert Opin Ther Targets 13(6):689-700.
12. Gotoh N (2008) Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins. Cancer Sci 99(7):1319-1325.
13. Hama J, Xu H, Goldfarb M, Weinstein DC (2001) SNT-1/FRS2alpha physically interacts with Laloo and mediates mesoderm induction by fibroblast growth factor. Mech Dev 109(2):195-204.
14. Gotoh N, et al. (2004) Tyrosine phosphorylation sites on FRS2alpha responsible for Shp2 recruitment are critical for induction of lens and retina. Proc Natl Acad Sci USA 101(49):17144-17149.
15. Kameda Y, Ito M, Nishimaki T, Gotoh N (2008) FRS2 alpha 2F/2F mice lack carotid body and exhibit abnormalities of the superior cervical sympathetic ganglion and carotid sinus nerve. Dev Biol 314(1):236-247.
16. Lanahan AA, et al. (2010) VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis. Dev Cell 18(5):713-724.
17. Drappa J, et al. (2003) Impaired T cell death and lupus-like autoimmunity in T cellspecific adapter protein-deficient mice. J Exp Med 198(5):809-821.
18. Sun Z, et al. (2012) VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. J Exp Med 209(7):1363-1377.
19. Sakurai Y, Ohgimoto K, Kataoka Y, Yoshida N, ShibuyaM (2005) Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proc Natl Acad Sci USA 102(4):1076-1081.
20. Zhou W, et al. (2009) FGF-receptor substrate 2 functions as a molecular sensor integrating external regulatory signals into the FGF pathway. Cell Res 19(10): 1165-1177.
21. Hadari YR, Gotoh N, Kouhara H, Lax I, Schlessinger J (2001) Critical role for the docking-protein FRS2 alpha in FGF receptor-mediated signal transduction pathways. Proc Natl Acad Sci USA 98(15):8578-8583.
22. Lanahan A, et al. (2013) The neuropilin 1 cytoplasmic domain is required for VEGFA-dependent arteriogenesis. Dev Cell 25(2):156-168.
23. Stoletov KV, Ratcliffe KE, Terman BI (2002) Fibroblast growth factor receptor substrate 2 participates in vascular endothelial growth factor-induced signaling. FASEB J 16(10):1283-1285.
24. Hatanaka K, Simons M, Murakami M (2011) Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation. Am J Physiol Heart Circ Physiol 300(1):H162-H172.
25. Chen PY, et al. (2012) FGF regulates TGF-β signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression. Cell Rep 2(6):1684-1696.
26. Eswarakumar VP, Horowitz MC, Locklin R, Morriss-Kay GM, Lonai P (2004) A gainof-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. Proc Natl Acad Sci USA 101(34):12555-12560.
27. Lin Y, Zhang J, Zhang Y, Wang F (2007) Generation of an Frs2alpha conditional null allele. Genesis 45(9):554-559.
28. Pitulescu ME, Schmidt I, Benedito R, Adams RH (2010) Inducible gene targeting in the neonatal vasculature and analysis of retinal angiogenesis in mice. Nat Protoc 5(9): 1518-1534.
29. Claxton S, et al. (2008) Efficient, inducible Cre-recombinase activation in vascular endothelium. Genesis 46(2):74-80.
30. MurakamiM, et al. (2011) FGF-dependent regulation of VEGF receptor 2 expression in mice. J Clin Invest 121(7):2668-2678.